Trade Summary

1 week ago, Olukotun Adeoye Y, serving as Dir at Arrowhead Pharmaceuticals, Inc. (ARWR), sold 10,000 shares at $67.66 per share, for a total transaction value of $676,623.00. Following this transaction, Olukotun Adeoye Y now holds 33,600 shares of ARWR.

This sale represents a 23.00% decrease in Olukotun Adeoye Y's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 19, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 4 days after the trade was made.

Arrowhead Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.